Bupropion Should Be Avoided in Patients with Any History of Seizure Disorder
Yes, bupropion should be avoided in patients with a documented history of seizure disorder, even if they have been seizure-free for five years. This is an absolute contraindication based on current FDA labeling and clinical practice guidelines.
Guideline-Based Contraindication
The evidence is unequivocal across multiple authoritative sources:
Bupropion is contraindicated in patients with any seizure disorder or history of seizures 1, 2. The 2016 AACE/ACE Obesity Guidelines explicitly state that "naltrexone ER/bupropion ER is contraindicated in patients with a seizure disorder, history of seizures, and high risk of seizures" 1. The 2022 AGA Guidelines similarly recommend that "naltrexone-bupropion ER should be avoided in patients with seizure disorders" 3.
The FDA drug label for bupropion is equally clear: patients should not take bupropion if they "have or had a seizure disorder or epilepsy" 2. The prescribing information states that "bupropion hydrochloride extended-release tablets (XL) are contraindicated in patients with a seizure disorder" 2.
Mechanism and Risk Profile
Bupropion lowers the seizure threshold through its mechanism as a norepinephrine and dopamine reuptake inhibitor 1. This proconvulsant effect is:
- Dose-dependent: Risk increases substantially with higher doses 2, 4
- Concentration-related: High serum levels increase seizure risk 5
- Present even at therapeutic doses: The incidence is approximately 0.1% at doses ≤450 mg/day in patients without seizure history 6, 4, but rises to 0.4% in clinical trials of naltrexone-bupropion combinations 1
Clinical Evidence
The evidence demonstrates that:
- In patients without seizure history, bupropion carries a baseline seizure risk of 0.35-0.48% at recommended doses 4
- Predisposing factors were present in over half of reported seizure cases 7, 4, indicating that patients with seizure history face substantially elevated risk
- A French pharmacovigilance analysis found that "taking more notice of the contraindications to use of bupropion could have prevented half the seizures reported" 7
- Case reports document new-onset seizures even in patients without traditional risk factors 8
Critical Clinical Pitfall
The five-year seizure-free period does not eliminate the contraindication. The guidelines and FDA labeling make no distinction based on time elapsed since last seizure. A history of seizure disorder indicates permanent structural or functional brain changes that create ongoing vulnerability when exposed to seizure threshold-lowering medications.
Alternative Medications
For patients requiring treatment for depression, smoking cessation, or weight management who have seizure history, safer alternatives include 1:
- For weight loss: Phentermine/topiramate, lorcaserin, liraglutide 3.0 mg, or orlistat (all have no known increased seizure risk)
- For smoking cessation: Varenicline or nicotine replacement therapy 9
- For depression: SSRIs, SNRIs (excluding bupropion), or other antidepressants with lower proconvulsant potential 5
The 2016 NCCN Smoking Cessation Guidelines note that "bupropion is contraindicated for patients with seizure risks" and specifically mention brain metastases as an example 9.
Bottom Line
Do not prescribe bupropion to this patient. The contraindication is absolute and applies regardless of how long the patient has been seizure-free. The risk of precipitating seizure recurrence outweighs any potential benefit, particularly given the availability of equally effective alternatives without this risk profile.